home / stock / orgo / orgo quote
Last: | $2.90 |
---|---|
Change Percent: | 1.4% |
Open: | $2.82 |
Close: | $2.90 |
High: | $2.91 |
Low: | $2.81 |
Volume: | 421,209 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.9 | $2.82 | $2.9 | $2.91 | $2.81 | 421,209 | 04-19-2024 |
$2.86 | $2.81 | $2.86 | $2.88 | $2.77 | 787,668 | 04-18-2024 |
$2.79 | $2.88 | $2.79 | $2.92 | $2.77 | 796,312 | 04-17-2024 |
$2.86 | $2.76 | $2.86 | $2.9 | $2.75 | 950,631 | 04-16-2024 |
$2.76 | $2.91 | $2.76 | $2.915 | $2.76 | 722,323 | 04-15-2024 |
$2.88 | $2.97 | $2.88 | $3.02 | $2.79 | 404,580 | 04-12-2024 |
$3 | $2.95 | $3 | $3.03 | $2.935 | 312,228 | 04-11-2024 |
$2.95 | $2.77 | $2.95 | $2.97 | $2.75 | 1,073,430 | 04-10-2024 |
$2.92 | $2.98 | $2.92 | $3.065 | $2.89 | 887,281 | 04-09-2024 |
$2.97 | $2.85 | $2.97 | $3.03 | $2.85 | 2,369,743 | 04-08-2024 |
$2.83 | $2.78 | $2.83 | $2.9 | $2.74 | 5,333,944 | 04-05-2024 |
$2.8 | $2.81 | $2.8 | $2.915 | $2.71 | 709,159 | 04-04-2024 |
$2.77 | $2.59 | $2.77 | $2.79 | $2.56 | 894,152 | 04-03-2024 |
$2.61 | $2.84 | $2.61 | $2.84 | $2.54 | 749,781 | 04-02-2024 |
$2.8 | $2.86 | $2.8 | $2.9006 | $2.72 | 253,851 | 04-01-2024 |
$2.84 | $2.74 | $2.84 | $2.865 | $2.72 | 253,053 | 03-29-2024 |
$2.84 | $2.74 | $2.84 | $2.865 | $2.72 | 253,053 | 03-28-2024 |
$2.76 | $2.66 | $2.76 | $2.78 | $2.6 | 406,976 | 03-27-2024 |
$2.62 | $2.66 | $2.62 | $2.685 | $2.61 | 381,010 | 03-26-2024 |
$2.62 | $2.63 | $2.62 | $2.685 | $2.585 | 377,949 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on ...
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today a...
2024-03-01 18:29:39 ET This earnings season, quite a few healthcare companies notched solid beats on revenue, earnings, or both. Unfortunately for its shareholders, Organogenesis Holdings (NASDAQ: ORGO) was not one of them. The wound care specialist published its fourth-quarter ...